Meditation science and statistics
Meditation is one of the most studied contemplative practices, and the evidence is strongest for specific outcomes rather than sweeping claims. The Q&As under this topic cover how many people meditate in the US and globally, whether meditation is scientifically proven, how it compares with medication for anxiety, its documented adverse effects, and its growing use in schools. Figures are drawn from peer-reviewed research and national surveys, with the nuance those sources actually support.
Can meditation have negative effects?
Yes. Farias et al. (2020) found 8.3% pooled adverse-effect rate, but this varies: 3.7% in RCTs vs. 33.2% in observational studies. Effects include increased anxiety and depersonalization. More common in intensive settings and among people with trauma histories.
Do schools teach meditation?
Increasingly, under the SEL banner. 83% of K-12 principals report using SEL curricula. But the MYRIAD trial (8,376 students) found universal school mindfulness did not outperform teaching-as-usual, largely because 80% didn’t complete homework.
How many Americans meditate?
The strongest peer-reviewed benchmark (NHIS data, published in Scientific Reports 2024) puts U.S. adult meditation use at 18.3% in 2022, or about 60.5 million people. A separate NCCIH-cited analysis gives 17.3%. Pew Research’s 2023 spirituality survey found 38% meditate at least a few times a month. These measure different aspects of the same behavior.
How many people meditate globally?
No single global figure exists. WIN World Survey (2024): India 79%, US 54%, Mexico 55% meditate ‘at least sometimes’ (broad definition). Stricter data: US 18.3% past-year, UK 16% ever learned, Germany 15.1% lifetime, France 9% weekly. India’s estimated 234 million IDY 2023 participants dwarfs all others.
Is meditation scientifically proven?
For anxiety, yes. A 2023 JAMA Psychiatry RCT found 8 weeks of MBSR was noninferior to escitalopram (a standard SSRI) for anxiety disorders. Evidence is also strong for depression relapse prevention and decent for sleep. For broader claims, the evidence is weaker. About 8.3% of research participants experience adverse effects.
How does meditation compare to medication for anxiety?
The best evidence: 8 weeks of MBSR was noninferior to 10-20 mg escitalopram for anxiety disorders (Hoge et al., 2023, JAMA Psychiatry, n=276). ‘Noninferior’ means ‘not worse than,’ not ‘better than.’ Meditation and medication are not mutually exclusive.